Blood centres across India that fail mandatory quality audits could soon be barred from carrying out routine testing until they identify the cause of the failure and correct it, according to proposals submitted to the country's top drug-regulatory advisory body.

The proposal, submitted to the apex advisory body on drug regulation, is aimed at tightening quality oversight of blood centres nationwide. As per the plan, a centre that does not clear the mandatory quality audit may be stopped from conducting routine testing.

Under the proposed arrangement, such a centre would be allowed to resume routine testing only after it identifies what went wrong and fixes the problem, according to the proposals.

The details of the proposal, including the timeline for its consideration, were not immediately clear. The move, if approved, would apply to blood centres across the country.